| Literature DB >> 17544673 |
L Gavernet1, I A Barrios, M Sella Cravero, L E Bruno-Blanch.
Abstract
As part of our search for potential anticonvulsant agents, a set of compounds were designed, synthesized, and evaluated against MES and PTZ tests. Bioisosteric functional group information was used to design a new functionality, sulfamides, that complies with the requirements of the pharmacophore previously defined. Some of the molecules showed a promising anticonvulsant profile as selective anti-MES drugs, being active at low concentrations (30mg/kg). The biological data were confirmed in Phase II of the Anticonvulsant Drug Development Program of the National Institute of Health.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17544673 DOI： 10.1016/j.bmc.2007.05.024
Source DB: PubMed Journal: Bioorg Med Chem ISSN： 0968-0896 Impact factor: 3.641